The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO

Published:2015-01 Issue:1 Volume:70 Page:74-80
ISSN:0009-9260
Container-title:Clinical Radiology
language:en
Short-container-title:Clinical Radiology

Author:

Zhang D.,Fa H.-B.,Zhou J.-T.,Li S.,Diao X.-W.,Yin W.

Funder

National Science Foundation of China

ChongQing Science & Technology Commission

Scientific Research Foundation for the Returned Overseas Chinese Scholars

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference47 articles.

1. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;Sperling;Alzheimers Dement,2011

2. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects;Shaw;Ann Neurol,2009

3. Alzheimer's disease biomarkers: correspondence between human studies and animal models;Sabbagh;Neurobiol Dis,2013

4. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults;Fagan;Arch Neurol,2007

5. CSF biomarkers for Alzheimer's disease: current utility and potential future use;Holtzman;Neurobiol Aging,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models;Frontiers in Pharmacology;2024-06-04

2. Advances in nanoprobes for molecular MRI of Alzheimer's disease;WIREs Nanomedicine and Nanobiotechnology;2024-03

3. Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer’s Disease;Cells;2023-09-14

4. A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s;Journal of Drug Targeting;2023-07-19

5. Nanomedicine-based immunotherapy for Alzheimer's disease;Neuroscience & Biobehavioral Reviews;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3